Citation
Karp P.D. Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Designin Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development, Blackwell Science Ltd, 1997.
Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Design
Read more from SRI
-
QED-C executive director named to the Quantum 100
Celia Merzbacher, executive director of the SRI-managed Quantum Economic Development Consortium, has been recognized for her role in strengthening the global quantum ecosystem.
-
New engines of technology-driven growth
Leveraging proven lab-to-market expertise, SRI is helping collaborators from Japan to New Jersey strengthen their science and technology ecosystems.
-
Vaalia Health: Causal AI for precision healthcare
With healthcare shifting toward at-home solutions, Vaalia Health is building on SRI’s AI innovations to make sure that efficient care is also effective care.